Successful Treatment of Pregnant Women with Coronavirus Disease While Maintaining Fetal Health: A Case Report

Coronavirus disease 2019 (COVID-19) is an emerging and potentially dangerous disease. Pregnancy is accompanied by partial suppression of the immune system, making pregnant women vulnerable to viral infections. This study aimed to report a pregnant woman with coronavirus. A 30-year-old female patient, third pregnancy, parity two, 18 weeks pregnant, who complained of mild cough, was referred to the health center. Diphenhydramine was prescribed by the visiting doctor. However, the next day, the coughs intensified, and she developed a fever of 38 degrees, shortness of breath, and high blood pressure of 140/90. She went to the emergency department of Imam Ali Hospital in Amol, Iran, and received oxygen therapy and serum therapy. Complete blood count, differential count, fasting blood sugar, and computerized tomography of lungs were requested. She received B complex seroflo spray and three doses of immunoglobulin. On the seventh day, the patient’s coughs and fever stopped. Moreover, the shortness of breath improved. The patient was quarantined at home for two weeks and used cefixime, diphenhydramine syrup, pantoprazole capsules, and seroflo spray for ten days at home. Approximately three months after COVID-19 treatment, the general condition of the patient was good, and she was monitored only for blood pressure daily